Breast Ca Growth Slowed by CDK4/6 Inhibitors

Published April 9, 2014

Breast Ca Growth Slowed by CDK4/6 Inhibitors
The studies also suggested that combining palbociclib with a drug that inhibited or suppressed estrogen, such as tamoxifen or letrozole, resulted in synergistic cell-killing activity compared with either agent by itself. The findings led to … Why the …
Read more on MedPage Today